Didn't notice this posted here. A fairly new article where they discuss that RTX would be quite effective and better at targeting the specific cells that cause us problems and allow us to drop the other meds quicker. Very short and easy to read summary of the study
"Rituximab depletes the body’s supply of cells thought to be responsible for ANCA production. Rituximab is a more targeted approach than the current standard of care, which involves nonspecific immunosuppression with potentially severe side effects."
"“Notably, rituximab patients who achieved remission within six months received no additional immunosuppression for more than one year,” said Daniel Rotrosen, M.D., director of NIAID’s Division of Allergy, Immunology and Transplantation. “Reducing the need for immunosuppressive drugs is of great benefit to the patient, lessening the risk of possible serious long-term side effects such as cancer, infertility and infection.”"
Therapy for severe vasculitis shows long-term effectiveness
Bookmarks